Brief: Aspira Women’S Health Inc. Announces Coverage For Ova1® In The Aim Specialty Health Laboratory Medicine Clinical Guidelines
July 8 (Reuters) - Aspira Women's Health Inc AWH.O :
* ASPIRA WOMEN’S HEALTH INC. ANNOUNCES COVERAGE FOR OVA1® IN
THE
AIM SPECIALTY HEALTH LABORATORY MEDICINE CLINICAL GUIDELINES
Source text for Eikon: ID:nGNX5mlpX4
Further company coverage: AWH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aspira Women's Health
See all newsBrief: Aspira Women’S Health Announces Receipt Of Delisting Notification From Nasdaq
Brief: Aspira Women's Health On April 4, Enters Equity Purchase Agreement With Triton Funds
Brief: Aspira Women's Health Files For Offering Up To 50 Units, 50 Mln Pre-Funded Units
Brief: Aspira Women's Health Interim CFO John Kallassy Resigns
Brief: Aspira Women's Health Fails To Regain Nasdaq Compliance